DBV Technologies
Developing non-invasive skin patch immunotherapy for severe food allergies like peanut and milk.
DBV | PA
Overview
Corporate Details
- ISIN(s):
- FR0010417345 (+3 more)
- LEI:
- 969500PVBQFWQKVDMD80
- Country:
- France
- Address:
- 107 AVENUE DE LA REPUBLIQUE, 92320 CHATILLON
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
DBV Technologies is a clinical-stage biopharmaceutical company focused on developing treatments for food allergies. The company's core technology is the proprietary Viaskin™ platform, an investigational form of epicutaneous immunotherapy (EPIT). This non-invasive patch technology is designed to deliver biologically active compounds, such as allergens, to the immune cells of the skin, thereby re-educating the immune system. DBV's development pipeline includes product candidates for common food allergies, with its lead program, Viaskin Peanut (DBV712), in late-stage clinical trials for peanut-allergic patients. Another key program is Viaskin Milk (DBV135) for milk allergies. Founded by pediatricians, the company is dedicated to improving the lives of patients with potentially life-threatening food allergies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-13 17:51 |
Regulatory Filings
Franchissement de seuils
|
French | 271.9 KB | ||
| 2025-11-12 05:50 |
ISS
DBV Technologies annonce la dernière visite du dernier patient dans l'essai cli…
|
French | 219.7 KB | ||
| 2025-11-12 05:50 |
ISS
DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clin…
|
English | 220.0 KB | ||
| 2025-10-30 21:30 |
Board/Management Information
DBV Technologies annonce la nomination de Philina Lee, Ph.D. au sein de son Con…
|
French | 197.8 KB | ||
| 2025-10-30 21:30 |
Board/Management Information
DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Direct…
|
English | 194.0 KB | ||
| 2025-10-28 21:25 |
Earnings Release
DBV Technologies Reports Third Quarter 2025 Financial Results
|
English | 272.3 KB | ||
| 2025-10-28 21:25 |
Earnings Release
DBV Technologies publie ses résultats financiers du troisième trimestre 2025
|
French | 274.7 KB | ||
| 2025-10-14 15:44 |
Major Shareholding Notification
Franchissement de seuils
|
French | 266.6 KB | ||
| 2025-06-20 12:46 |
Major Shareholding Notification
Franchissement de seuils
|
French | 124.2 KB | ||
| 2025-06-17 16:58 |
Major Shareholding Notification
Franchissement de seuils
|
French | 107.2 KB | ||
| 2025-06-12 22:05 |
Earnings Release
DBV Technologies to Participate in Upcoming EAACI Congress 2025
|
English | 275.8 KB | ||
| 2025-06-12 22:05 |
Regulatory Filings
DBV Technologies participera au prochain congrès EAACI 2025
|
French | 269.7 KB | ||
| 2025-06-11 22:30 |
AGM Information
DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2025
|
French | 179.9 KB | ||
| 2025-06-11 22:30 |
Declaration of Voting Results & Voting Rights Announcements
DBV Technologies Announces the Voting Results of its 2025 Combined General Meet…
|
English | 179.7 KB | ||
| 2025-06-04 22:32 |
Declaration of Voting Results & Voting Rights Announcements
Information Regarding the Total Number of Voting Rights and Total Number of Sha…
|
English | 169.6 KB |
Automate Your Workflow. Get a real-time feed of all DBV Technologies filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DBV Technologies
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DBV Technologies via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-09 | N/A | Other | Other | 2,483,161 | 7,449,483.00 EUR |
Peer Companies
